Gene therapy has been successfully used to treat a number of diseases, including immune deficiencies, hereditary blindness, hemophilia and, recently, Huntington's disease, a fatal neurological disorder.
Feb 27, 2026
0
0
A large new study suggests that higher levels of a common amino acid called tyrosine may be linked to a shorter lifespan in men.
Feb 27, 2026
0
0
Scientists at the University of California, Irvine's School of Pharmacy & Pharmaceutical Sciences have discovered how muscle stem cells "flip a switch" to rebuild damaged muscle—a finding that could help address muscle ...
Feb 27, 2026
0
0
Nitrous oxide used for sedating patients during dental appointments has a significant environmental impact, with wide variation in use and wastage across the UK, according to a new study by UCL (University College London) ...
Feb 27, 2026
0
0
Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally intended, but by retraining ...
Feb 27, 2026
0
0
Men are more susceptible than women to skin infections caused by Staphylococcus aureus bacteria, but the biological basis for this disparity has remained unclear. A new study led by UT Southwestern Medical Center researchers ...
Feb 27, 2026
0
0
Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk, according to research published online Feb. 23 in Nutrition & Diabetes.
Feb 27, 2026
0
0
Certain imagery-based techniques can reduce the fear of failure that results from difficult childhood memories, according to research by scientists from SWPS University and the Nencki Institute of Experimental Biology. The ...
Feb 27, 2026
0
0
The dominant theory in neuroscience has been that the sensory processing circuits in our brain are finalized in early childhood and fixed afterward. A recently published study, however, overturned this widely believed theory, ...
Feb 27, 2026
0
0
Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in persons with human immunodeficiency virus (HIV) and medication adherence challenges, according to a ...
Feb 27, 2026
0
0
